FDA Concludes DECADRON Was Not Withdrawn for Safety or Effectiveness Reasons
April 09, 2025
April 09, 2025
WASHINGTON, April 9 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has announced that DECADRON (dexamethasone sodium phosphate) solution/drops, equivalent to 0.1 percent phosphate, was not pulled from the market due to safety or efficacy concerns. This decision clears the way for continued approval of generic versions of the drug, provided they comply with existing legal and regulatory standards.
The determination, published in the Federal R . . .
The determination, published in the Federal R . . .